Equities research analysts expect Collegium Pharmaceutical Inc (NASDAQ:COLL) to report sales of $72.39 million for the current quarter, according to Zacks. Five analysts have provided estimates for Collegium Pharmaceutical’s earnings, with the highest sales estimate coming in at $78.40 million and the lowest estimate coming in at $60.70 million. Collegium Pharmaceutical posted sales of $3.56 […]
